跳至主要内容
临床试验/ISRCTN36672232
ISRCTN36672232已完成不适用

A randomised placebo controlled double-blind cross-over trial of the Polypill on risk factor reduction

Queen Mary University of London (UK)0 个研究点目标入组 100 人开始时间: 2011年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Men and women aged 50 and over, without selection on the basis of other risk factors, for whom there is no medical contra-indication to taking the Polypill

排除标准

  • 1. Clinical history of cardiovascular disease
  • 2. Any illness judged to contra-indicate participation in the trial
  • 3. Taking other specified drugs: lithium, cyclosporine or other calcineurin inhibitors, erythromycin or other macrolides, azole antifungals, ritonavir or other protease inhibitors, amiodarone

研究者

发起方
Queen Mary University of London (UK)

相似试验